ARTICLE INFO

Article Type

Case Report

Authors

Haddadi   N. (*)






(*) ‎“Sarem Fertility & Infertility Research Center (SAFIR)” and “Sarem Cell Research Center (SCRC)” ‎, Sarem Women’s Hospital, Tehran, Iran

Correspondence

Address: Sarem Women’s Hospital, Basij Square, Phase 3, Ekbatan Town, Tehran, Iran. Postal Code: 1396956111‎
Phone: ‎+98 (21) 44670888‎
Fax: ‎+98 (21) 44670432‎
n_hadadi@yahoo.com

Article History

Received:   August  12, 2016
Accepted:   January 10, 2017
ePublished:   February 15, 2017

ABSTRACT

Information & Methods About one-third of embryos with Nuchal Thickening (NT) have chromosomal ‎abnormalities. One of these abnormalities is Klinefelter syndrome (47XXY). The ‎aim of this case report was to indicate the importance of prenatal diagnosis with ‎consideration of anomalies reports in both screenings of the first and second ‎trimester of pregnancy as well as the importance of NT and the need for further ‎chromosomal studies in these conditions.‎ A 29-year-old woman with the first pregnancy was referred to Screening Clinic of ‎Sarem Hospital for the first stage of aneuploidy screening in gestational age of 13 ‎weeks and 2 days. The screening results of the first trimester were normal and in ‎the second screening, the Quad marker testing (four tests of Inhibin A, Free β-hCG, ‎AFP, and UE3) was conducted in gestational age of 16 weeks; the risk of Fetal ‎Neural Tube Defects and Down syndrome were reported again in the low-risk ‎range. Amniocentesis was asked for the patient for a definitive diagnosis because ‎of the high NT range. In the review and analysis of amniotic fluid cells, karyotype ‎was reported as 47XXY (Klinefelter syndrome).‎
Conclusion In aneuploidy screening, only estimating the risk of common trisomies of 13, 18, ‎and 21 is not the case. NT amount must be examined separately. The prenatal ‎diagnosis of these disorders is effective in planning and future prognosis of ‎pregnancy. Klinefelter syndrome is one of those chromosomal abnormalities, ‎which occurs as a XXY karyotype with an outbreak of 1 in 10,000 in boys, and, ‎unfortunately, it is not diagnosed until the puberty after manifesting itself as a ‎demonstration of hypogonadism. Early diagnosis and alternative hormone ‎therapy can make natural maturation process in these cases. ‎


CITATION LINKS

[1]Nicolaides K. The 11-13+ 6 Weeks Scan. London: Fetal Medicine Foundation; 2004
[2]Karami F, Noori-Daloii M, Modarressi M. Non-invasive screening methods of down syndrome through maternal circulation. Novin Genetics. 2015;10(2):135-50 [Persian]
[3]Miron P, Côté YP, Lambert J. Nuchal translucency thresholds in prenatal screening for Down syndrome and trisomy 18. J Obstet Gynaecol Can. 2009 Mar;31(3):227-235.
[4]Palomaki GE, Lee JES, Canick JA, McDowell GA, Donnenfeld AE. Technical standards and guidelines: Prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurements. Genet Med. 2009;11(9):669-81.
[5]Islamic Republic of Iran Ministry of Health and Medical Education. Fetal chromosomal abnormalities prevent programs down syndrome [Online]. Tehran: Ministry of Health Medical Education; 2015 [Update 2016 May 10]. Available From: https://goo.gl/NvQ8Hz. [Persian]
[6]Vallian Broojeni S. Prenatal diagnosis of genetic diseases. J Labratoratory Diagn. 2013(19):30-6. [Persian]
[7]Piri S. Screening of chromosomal abnormalities in 1st and 2nd trimester of pregnancy: The role of fetal echocardiographic genetic sonography. J Iran Obstetr Gynecol. 2010;5(1):7-12. [Persian]
[8]Driscoll DA, Gross SJ. Screening for fetal aneuploidy and neural tube defects. Genet Med. 2009;11(11):818-21.
[9]Vladareanu R, Tutunaru D, Alexandru B, Veduta A, Zvanca M. Ultrasound in prenatal diagnosis of triploidy and Turner syndrome. Gynaecol Perinatol. 2006;15(4):192-201.
[10]Zoppi M, Ibba R, Floris M, Monni G. Fetal nuchal translucency screening in 12 495 pregnancies in Sardinia. Ultrasound Obstet Gynecol. 2001;18(6):649-51.
[11]Spitczok von Brisinski I. Klinefelter syndrome: the commonest form of hypogonadism, but often overlooked or untreated. Psychological and neurological problems. Dtsch Arztebl Int. 2013;110(40):675.
[12]Sanz‐Cortés M, Raga F, Cuesta A, Claramunt R, Bonilla‐Musoles F. Prenatally detected double trisomy: Klinefelter and Down syndrome. Prenat Diagn. 2006;26(11):1078-80.
[13]Mishra SR, Bisht JS, Kumar M, Kumar S, Gaur K, Kumar R, et al. Double aneuploidy 48,XXY,+21 in a fetus with congenital abnormalities. Der Pharmacia Lettre. 2014;6(3):351-4.
[14]Shu X, Zou C, Shen Z. Double aneuploidy 48, XXY,+ 21 associated with a aongenital aeart aefect in a neonate balkan. J Med Genet. 2013; 16(2): 85–90.
[15]Jo DG, Seo JT, Lee JS, Park SY, Kim JW. Klinefelter syndrome diagnosed by prenatal screening tests in high-risk groups. Korean J Urol. 2013;54(4):263-5.
[16]Lichtenbelt KD, Alizadeh BZ, Scheffer PG, Stoutenbeek P, Schielen PC, Page‐Christiaens LC, et al. Trends in the utilization of invasive prenatal diagnosis in the Netherlands during 2000–2009. Prenat Diagn. 2011;31(8):765-72.